IP Library Granted Patent US 9,333,189
Granted Patent B2
US 9,333,189 · App. 13/017,173 · Granted May 10, 2016

Taxane- and taxoid-protein compositions

Inventors: Jonathan F. Head (Baton Rouge, LA); Robert L. Elliott (Baton Rouge, LA)
Assignee: ONCBIOMUNE, INC.
A61K31/337A61K9/0019A61K38/1808A61K38/2257A61K38/38A61K38/40A61K45/06A61K47/42A61K47/44A61K47/483A61K47/48284
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,189
App. No.
13/017,173
Granted
May 10, 2016
Kind
B2
Abstract

Compositions comprising a taxane or taxoid, such as paclitaxel, and a protein, such as albumin or a metal-transferrin, such as gallium-transferrin, can be prepared by combining an aqueous protein solution with a second solution containing the taxane or taxoid, a non-ionic surfactant, and an alcohol; adjusting the pH of the combined solutions to between about 7.9 and about 8.3; and purifying the pH-adjusted solution to remove solutes having a molecular weight less than 10,000 Da. Such compositions can be prepared that are substantially free of non-ionic surfactants, such as Cremophor EL, and are useful in the treatment of cancers, such as breast cancer.

Claims (11)

1. A composition comprising A) a complex consisting of (i) a metal-transferrin; and (ii) a taxane or taxoid that inhibits mitosis; and B) a pharmaceutically acceptable diluent,

wherein the taxane or taxoid either (a) is bonded with the metal-transferrin via a direct bond between the taxane or taxoid and the metal-transferrin; or (b) forms a non-covalent complex with the metal-transferrin;

the transferrin of the metal-transferrin is human transferrin, bovine transferrin, serotranferrin, lactotransferrin, ovotransferrin, or melanotransferrin, and

the composition substantially lacks solutes having a molecular weight less than 10,000 Da.

2. The composition of claim 1 , wherein the taxane or taxoid is paclitaxel or docetaxel.

3. The composition of claim 1 , the metal-transferrin is gallium-transferrin, iron-transferrin, indium-transferrin, zinc-transferrin, manganese-transferrin, platinum-transferrin, or a mixture thereof.

4. The composition of claim 3 , the metal-transferrin is gallium-transferrin.

5. The composition of claim 1 , wherein the taxane or taxoid is paclitaxel.

6. The composition of claim 5 , the metal-transferrin is gallium-transferrin.

7. The composition claim 1 , wherein the taxane or taxoid is bonded with the metal-transferrin via a direct bond.

8. The composition of claim 1 , wherein the taxane or taxoid forms a non-covalent complex with the metal-transferrin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: ONCBIOMUNE, INC.
To: ONCBIOMUNE SUB, INC.
Reel/Frame 056834/0631 →
CHANGE OF NAME Recorded Jun 5, 2015
From: ONCBIOMUNE, L.L.C.
To: ONCBIOMUNE, INC.
Reel/Frame 035832/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: HEAD, JONATHAN F.; ELLIOTT, ROBERT L.
To: ONCBIOMUNE, L.L.C.
Reel/Frame 026002/0599 →
Continuity (2)
Provisional Application 61301006 · Feb 3, 2010
Related Publication 20110190204A1 · Aug 4, 2011